These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19706567)

  • 1. Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications.
    Setlik J; Bond GR; Ho M
    Pediatrics; 2009 Sep; 124(3):875-80. PubMed ID: 19706567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate abuse in Texas, 1998-2004.
    Forrester MB
    J Toxicol Environ Health A; 2006 Jun; 69(12):1145-53. PubMed ID: 16728377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The misuse and diversion of prescribed ADHD medications by college students.
    Rabiner DL; Anastopoulos AD; Costello EJ; Hoyle RH; McCabe SE; Swartzwelder HS
    J Atten Disord; 2009 Sep; 13(2):144-53. PubMed ID: 19448150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.
    Hughes AA; Bogdan GM; Dart RC
    Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications.
    Wilens TE; Gignac M; Swezey A; Monuteaux MC; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):408-14. PubMed ID: 16601645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
    Kollins SH
    J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.
    Darredeau C; Barrett SP; Jardin B; Pihl RO
    Hum Psychopharmacol; 2007 Dec; 22(8):529-36. PubMed ID: 17910020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ADHD and its treatment on substance abuse in adults.
    Wilens TE
    J Clin Psychiatry; 2004; 65 Suppl 3():38-45. PubMed ID: 15046534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmedical use of prescription stimulants in the United States.
    Kroutil LA; Van Brunt DL; Herman-Stahl MA; Heller DC; Bray RM; Penne MA
    Drug Alcohol Depend; 2006 Sep; 84(2):135-43. PubMed ID: 16480836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescriptions for ADHD medication, 2004-08.
    Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
    Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse.
    Horner BR; Scheibe KE
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):30-6. PubMed ID: 9000778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.